Eurofins Biomnis
François Cornu has a diverse work experience in various companies and organizations. In 1987, they worked with the INSERM as part of the CNRS UPR 41 Recombinaisons Génétiques project. From 1990 to 1991, they joined the AP-HP and worked in the service of Médecine nucléaire - Laboratoire de Radio Immunologie - Pitié Salpêtrière. In 2010, François Cornu joined COFRAC as a technical evaluator until 2015. François then became the President of SBBPL, which later became ARMORIS, from 2011 to 2015. Since 2015, François Cornu has been serving as the President of Eurofins Biomnis at the Laboratoire Eurofins Biomnis.
François CORNU completed their education with the following chronological information:
- From 1986 to 1987, they attended Institut Pasteur and obtained a Diplôme d'Immunologie Générale, specializing in Immunology.
- From 1989 to 1991, François CORNU studied at CEA Saclay, where they earned a DESC de Radiobiologie et Radiopharmacie. Their field of study was Radioimmunology.
- In 1987 to 1988, they attended Faculté Sciences Paris X and received a DEA Bases Fondamentales de l'Oncogénèse. The degree focused on Molecular Biology.
- Starting from 1984, François CORNU pursued their medical training at APHP as an Interne des Hôpitaux de Paris in the field of Biologie Médicale, but the end year is not available in the provided information.
This person is not in any teams
This person is not in any offices
Eurofins Biomnis
European leader in the sector of specialized medical pathology, Eurofins Biomnis carries out over 32,000 analyses per day from a range of over 2,500 available tests, including specialized tests for which the company has the appropriate authorizations. Founded in 1897 by Marcel Mérieux, Eurofins Biomnis remains the leader in the field of specialized medical pathology in France. It has kept its position through continuous technological innovation and investment, particularly in areas such as female biology, oncology and personalized medicine, as well as chromosomal and molecular genetics. The laboratory also stands out through its expertise in clinical research and biobanking, thanks to its dedicated infrastructure. With 120 years of expertise and innovation in the service of medical pathology, Eurofins Biomnis is the core of the Clinical Diagnostics division in Europe and has its eyes set on its international development.